{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0009610/OMIM:250950","label":"3-methylglutaconic aciduria, type I","mondoId":"MONDO:0009610","onsetQualifier":null,"recordKeys":["1f98afe8c2a2205f90c3870db0732fa2d0b5d84863b7d687a9854730bef1528d","285c381012b3b6d8671a9b9b56fcad76291e56126060cf2870bce43d8b18644c","2a3a206da817417369d0ef52f580704c801149049b4bfb0a12903c43603a05a1","39147149396a090e49b785f1f38c54f8bbb92e294c57634f6b1ca07825b104b6","43506f5f35a10c1efd9c806a66cf922bb61d4288c08b51f7084a2d2291895020","547f02d3a4cad6810700087d0e65c9c793f98c8b8dcd890923da58756e9eb196","562bc3792633d5e4096e7b8f771bb0bf5c7989c316ed1225fccc7fb525da3f7b","60291f8d69a2a992cac5c6986347adf27e2689bbac6bcf43d5323a87283df16f","7493e13ba8a2dc42a7e0aa6098a55e5f89c2ed5e12b66d7b8e0c016d66f45146","75c07309efb4898f7266a709037a73d421061fcc16ab9945f69f02479f638d54","7c5ed383f9cb7e600710dfcdc6a384a9c58a5531fb12a85de27da82fed53ba21","82b4a0da1ea9275e12e71b9b5c88ef96442bb945f6bffa64d72495c6eff5cdbd","8c32bfb1abdbc1f5c5d1be9dc5b21777752972b6c6db1254e07e9b1728b42eaa","98c001a386917690fa62c00aa62149bffbd3243d3ce90703c30dd8c56eabcf74","a46e794eac68aa451bed828411825b7218f5d0822d05d5e25b74b1c0175bb7e0","a7e5b915755fb0cd03ff7d488cea34c5d27d81b9e073310deb7aa83d98cb2a9f","b499a150dc318d02315a536a8edb0ed8c58c4e44f46c718e96dfc2ef4788867a","bb38214ef718798638228699febfdd9b4cb31b474cabcafa46f351adb200b141","bc4bb3c4d38eb8d06de939672ba26ded8187c4f18c3bc64f6203107a6f318451","c2f84d6f106ef34225e5c787708b730495db4ce398a159bba1dd911b4ab5ad88","cb5033d282674acc418973774a1756f4b9c39b9e62e4451c25dad28950525c0a","d0210afa41e0b4277e62a08765d27f0956a3c31103e49988b6b5ed80cdae4f2e","d51b31dacedd2e6100119d23223fc5cbca3a980faef9a476c2ad36420b0a34bd","fc5e652c0dea8a444d571fd47d49202c596ca5b4931fde58178aa6f43b6693c9"],"recordQualifiers":{},"scopeLabel":"OMIM:250950","sourceIds":["OMIM:250950"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0009610/ORPHA:67046","label":"3-methylglutaconic aciduria type 1","mondoId":"MONDO:0009610","onsetQualifier":null,"recordKeys":["16b31dd280513cbd360cd54905a1e591faccfc872e979594e65ab0aa407f142d","1a3510e6b9669bfb4925067b2b233468db2d9d7a6e40eecba38f87cf3ef6f8b8","1d2c997c3ff9660314ffa5e829acd0c8139fedfd1ec98fe9e0f9558950c42465","48360f90ddcf308263609cacb324acae237d4664e728453b18a5f31a33b6cfe6","5803b0604a36d514b63d51ea6b8a0a6ec1eb51278d0e5fc1242d320ca8202a4c","5ed4a289f17df2f033570b387566d2c3fd8e66d118d1bd1846c11e45da38e0ae","67f1dfffa2ef41d2c2519381eb161bb298edb97fa1f4ede78226e85dab4d4263","86522747aa8061e76a6dadb38fc72fc65458ebc8a24438b52c25672277f7e7b9","b310dd97b86a97d83ec82260970812b3a13ff3384025ebee232b0d0de58462bf","dfc27f24b24c834154dcccfea5b5e8d33211d661a39305c7dcca9c3e66c1a445","e979d1635be546352654f2d233d02fd67aa4c724acf8b8d6aeef1f485efd8d67","f0dd7c435be6a85c4be1d4bb3e622d733af937c08c0c772210b07c9d05e2e6ba","fa46d3cd1a6bd7d953043c50581f3de5b0d9ea680f7d141f1909ef1939699747"],"recordQualifiers":{},"scopeLabel":"ORPHA:67046","sourceIds":["ORPHA:67046"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0009610/OMIM:250950","MONDO:0009610/ORPHA:67046"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":37,"sourceGroups":{"omim":12,"orphanet":13,"published":12}},"features":[{"hpoId":"HP:0003535","label":"3-Methylglutaconic aciduria","primary":false},{"hpoId":"HP:0002134","label":"Abnormal basal ganglia morphology","primary":false},{"hpoId":"HP:0002500","label":"Abnormal cerebral white matter morphology","primary":false},{"hpoId":"HP:0001251","label":"Ataxia (coordination difficulty)","primary":false},{"hpoId":"HP:0002305","label":"Athetosis","primary":false},{"hpoId":"HP:0002059","label":"Cerebral atrophy","primary":false},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":false},{"hpoId":"HP:0001259","label":"Coma","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language","primary":false},{"hpoId":"HP:0000726","label":"Dementia","primary":false},{"hpoId":"HP:0001260","label":"Dysarthria","primary":false},{"hpoId":"HP:0001332","label":"Dystonia","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0002373","label":"Febrile seizure (within the age range of 3 months to 6 years)","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0001347","label":"Hyperreflexia","primary":false},{"hpoId":"HP:0001943","label":"Hypoglycemia","primary":false},{"hpoId":"HP:0002352","label":"Leukoencephalopathy","primary":false},{"hpoId":"HP:0001942","label":"Metabolic acidosis","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0001270","label":"Motor delay","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0002073","label":"Progressive cerebellar ataxia","primary":false},{"hpoId":"HP:6000577","label":"Reduced tissue 3-methylglutaconyl-CoA hydratase activity","primary":false},{"hpoId":"HP:0001250","label":"Seizures","primary":false},{"hpoId":"HP:0000742","label":"Self-mutilation","primary":false},{"hpoId":"HP:0000736","label":"Short attention span","primary":false},{"hpoId":"HP:0001285","label":"Spastic tetraparesis","primary":false},{"hpoId":"HP:0002510","label":"Spastic tetraplegia","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0000020","label":"Urinary incontinence","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0009610","records":[{"frequencyKind":"range","key":"16b31dd280513cbd360cd54905a1e591faccfc872e979594e65ab0aa407f142d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001943","is_excluded":false,"label":"Hypoglycemia","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1a3510e6b9669bfb4925067b2b233468db2d9d7a6e40eecba38f87cf3ef6f8b8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003535","is_excluded":false,"label":"3-Methylglutaconic aciduria","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1d2c997c3ff9660314ffa5e829acd0c8139fedfd1ec98fe9e0f9558950c42465","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"1f98afe8c2a2205f90c3870db0732fa2d0b5d84863b7d687a9854730bef1528d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002373","is_excluded":false,"label":"Febrile seizure (within the age range of 3 months to 6 years)","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"285c381012b3b6d8671a9b9b56fcad76291e56126060cf2870bce43d8b18644c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"1/10","hpo_id":"HP:0000742","is_excluded":false,"label":"Self-mutilation","onset_id":null,"reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2a3a206da817417369d0ef52f580704c801149049b4bfb0a12903c43603a05a1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"4/20","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"39147149396a090e49b785f1f38c54f8bbb92e294c57634f6b1ca07825b104b6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002059","is_excluded":false,"label":"Cerebral atrophy","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"43506f5f35a10c1efd9c806a66cf922bb61d4288c08b51f7084a2d2291895020","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"1/10","hpo_id":"HP:0002305","is_excluded":false,"label":"Athetosis","onset_id":null,"reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"48360f90ddcf308263609cacb324acae237d4664e728453b18a5f31a33b6cfe6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"547f02d3a4cad6810700087d0e65c9c793f98c8b8dcd890923da58756e9eb196","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"3/10","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"562bc3792633d5e4096e7b8f771bb0bf5c7989c316ed1225fccc7fb525da3f7b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"10/10","hpo_id":"HP:0003535","is_excluded":false,"label":"3-Methylglutaconic aciduria","onset_id":null,"reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"5803b0604a36d514b63d51ea6b8a0a6ec1eb51278d0e5fc1242d320ca8202a4c","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5ed4a289f17df2f033570b387566d2c3fd8e66d118d1bd1846c11e45da38e0ae","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"60291f8d69a2a992cac5c6986347adf27e2689bbac6bcf43d5323a87283df16f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002352","is_excluded":false,"label":"Leukoencephalopathy","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"67f1dfffa2ef41d2c2519381eb161bb298edb97fa1f4ede78226e85dab4d4263","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"7493e13ba8a2dc42a7e0aa6098a55e5f89c2ed5e12b66d7b8e0c016d66f45146","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:6000577","is_excluded":false,"label":"Reduced tissue 3-methylglutaconyl-CoA hydratase activity","onset_id":null,"reference":"PMID:3082934","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"75c07309efb4898f7266a709037a73d421061fcc16ab9945f69f02479f638d54","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"2/10","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7c5ed383f9cb7e600710dfcdc6a384a9c58a5531fb12a85de27da82fed53ba21","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"2/10","hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":"HP:0003581","reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"82b4a0da1ea9275e12e71b9b5c88ef96442bb945f6bffa64d72495c6eff5cdbd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"86522747aa8061e76a6dadb38fc72fc65458ebc8a24438b52c25672277f7e7b9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001259","is_excluded":false,"label":"Coma","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"8c32bfb1abdbc1f5c5d1be9dc5b21777752972b6c6db1254e07e9b1728b42eaa","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002510","is_excluded":false,"label":"Spastic tetraplegia","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"98c001a386917690fa62c00aa62149bffbd3243d3ce90703c30dd8c56eabcf74","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"1/10","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a46e794eac68aa451bed828411825b7218f5d0822d05d5e25b74b1c0175bb7e0","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a7e5b915755fb0cd03ff7d488cea34c5d27d81b9e073310deb7aa83d98cb2a9f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0100543","is_excluded":false,"label":"Cognitive impairment","onset_id":null,"reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b310dd97b86a97d83ec82260970812b3a13ff3384025ebee232b0d0de58462bf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001285","is_excluded":false,"label":"Spastic tetraparesis","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"b499a150dc318d02315a536a8edb0ed8c58c4e44f46c718e96dfc2ef4788867a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"4/10","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"bb38214ef718798638228699febfdd9b4cb31b474cabcafa46f351adb200b141","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"bc4bb3c4d38eb8d06de939672ba26ded8187c4f18c3bc64f6203107a6f318451","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c2f84d6f106ef34225e5c787708b730495db4ce398a159bba1dd911b4ab5ad88","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001270","is_excluded":false,"label":"Motor delay","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"cb5033d282674acc418973774a1756f4b9c39b9e62e4451c25dad28950525c0a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000736","is_excluded":false,"label":"Short attention span","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"d0210afa41e0b4277e62a08765d27f0956a3c31103e49988b6b5ed80cdae4f2e","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000020","is_excluded":false,"label":"Urinary incontinence","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"d51b31dacedd2e6100119d23223fc5cbca3a980faef9a476c2ad36420b0a34bd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"PCS","frequency_raw":"4/6","hpo_id":"HP:0002500","is_excluded":false,"label":"Abnormal cerebral white matter morphology","onset_id":null,"reference":"PMID:20855850","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"dfc27f24b24c834154dcccfea5b5e8d33211d661a39305c7dcca9c3e66c1a445","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002134","is_excluded":false,"label":"Abnormal basal ganglia morphology","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e979d1635be546352654f2d233d02fd67aa4c724acf8b8d6aeef1f485efd8d67","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002073","is_excluded":false,"label":"Progressive cerebellar ataxia","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f0dd7c435be6a85c4be1d4bb3e622d733af937c08c0c772210b07c9d05e2e6ba","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fa46d3cd1a6bd7d953043c50581f3de5b0d9ea680f7d141f1909ef1939699747","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:67046","disease_name":"3-methylglutaconic aciduria type 1","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:67046","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"fc5e652c0dea8a444d571fd47d49202c596ca5b4931fde58178aa6f43b6693c9","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:250950","disease_name":"3-methylglutaconic aciduria, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"OMIM:250950","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"3-methylglutaconyl-coa-hydratase-deficiency","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"3-methylglutaconic aciduria type 1"},"schemaVersion":1}